ecteinascidin 743 has been researched along with Fibrosarcoma in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allavena, P; Belgiovine, C; Colombo, FS; D'Incalci, M; Digifico, E; Frapolli, R; Liguori, M; Meroni, M | 1 |
| Aquilano, M; Becherini, C; Campanacci, DA; Francolini, G; Greto, D; Livi, L; Loi, M; Mangoni, M; Melica, ME; Salvatore, G; Salvestrini, V; Santini, C; Sottili, M; Talamonti, C; Valzano, M | 1 |
| Allavena, P; Belgiovine, C; Bello, E; Beltrame, L; Craparotta, I; D'Incalci, M; Frapolli, R; Galmarini, CM; Liguori, M; Mannarino, L; Mantovani, A; Marchini, S; Paracchini, L | 1 |
| Allavena, P; Anichini, A; Anselmo, A; Belgiovine, C; Beltrame, L; Casali, PG; D'Incalci, M; Erba, E; Frapolli, R; Fuso Nerini, I; Galmarini, CM; Germano, G; Liguori, M; Mantovani, A; Marchini, S; Mortarini, R; Nebuloni, M; Pasqualini, F; Pesce, S; Pilotti, S; Sanfilippo, R; Uboldi, S; van Rooijen, N; Zucchetti, M | 1 |
| Bulut, D; Chromik, AM; Daigeler, A; Goertz, O; Hahn, S; Harati, K; Hirsch, T; Klein-Hitpass, L; Lehnhardt, M; Uhl, W | 1 |
5 other study(ies) available for ecteinascidin 743 and Fibrosarcoma
| Article | Year |
|---|---|
Inhibition of tumor-associated macrophages by trabectedin improves the antitumor adaptive immunity in response to anti-PD-1 therapy.
Topics: Adaptive Immunity; Animals; Antineoplastic Agents, Alkylating; Fibrosarcoma; Immune Checkpoint Inhibitors; Male; Mice; Mice, Inbred C57BL; Mice, Nude; Neoplasms, Experimental; Programmed Cell Death 1 Receptor; Trabectedin; Tumor Escape; Tumor-Associated Macrophages | 2021 |
Radiosensitizing Effect of Trabectedin on Human Soft Tissue Sarcoma Cells.
Topics: Antineoplastic Agents, Alkylating; Fibrosarcoma; Humans; Leiomyosarcoma; Liposarcoma; Radiation-Sensitizing Agents; Rhabdomyosarcoma; Sarcoma; Soft Tissue Neoplasms; Trabectedin; Tumor Microenvironment | 2022 |
Lurbinectedin reduces tumour-associated macrophages and the inflammatory tumour microenvironment in preclinical models.
Topics: Animals; Antineoplastic Agents, Alkylating; Apoptosis; Carbolines; Caspase 8; Cell Adhesion; Cell Movement; Chemokine CCL2; Dioxoles; Down-Regulation; Female; Fibrosarcoma; Gene Expression; Gene Expression Profiling; Heterocyclic Compounds, 4 or More Rings; HL-60 Cells; Humans; Interleukin-8; Leukocyte Count; Macrophages; Mice; Mice, Inbred C57BL; Monocytes; Neovascularization, Pathologic; Ovarian Neoplasms; rho GTP-Binding Proteins; Tetrahydroisoquinolines; Trabectedin; Tumor Microenvironment; U937 Cells; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2017 |
Role of macrophage targeting in the antitumor activity of trabectedin.
Topics: Animals; Antineoplastic Agents, Alkylating; Apoptosis; Blotting, Western; Carcinoma, Lewis Lung; Caspase 8; Cell Proliferation; Dioxoles; Female; Fibrosarcoma; Flow Cytometry; Humans; Immunoenzyme Techniques; Macrophages; Mice; Monocytes; Myeloid Cells; Neovascularization, Pathologic; Ovarian Neoplasms; Phagocytes; Signal Transduction; Tetrahydroisoquinolines; Trabectedin; Tumor Cells, Cultured | 2013 |
TRAIL and taurolidine enhance the anticancer activity of doxorubicin, trabectedin and mafosfamide in HT1080 human fibrosarcoma cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Growth Processes; Cell Line, Tumor; Cyclophosphamide; Dioxoles; Doxorubicin; Drug Synergism; Fibrosarcoma; Humans; Recombinant Proteins; Taurine; Tetrahydroisoquinolines; Thiadiazines; TNF-Related Apoptosis-Inducing Ligand; Trabectedin | 2012 |